Quick answer: Longevity skincare no longer seeks to erase wrinkles on the surface. It tackles the biological mechanisms that cause the skin to age: cellular senescence, mitochondrial dysfunction, degradation of the extracellular matrix. This preventive and cellular approach redefines what it means to “take care of your skin over the long term.”
Wrinkles remain the most visible symbol of ageing. Yet dermatology researchers and formulators now consider them a symptom, not a cause. This shift in focus towards the root causes of skin ageing represents one of the most important changes in skincare science in two decades.
The market is following this evolution. The global anti-ageing sector was valued at approximately 71.6 billion dollars in 2024 and is expected to reach 143 billion by 2033, with an annual growth rate of around 7.9%. It is not demand for conventional anti-wrinkle creams that is driving this growth: it is the increasing interest in active ingredients that target biological ageing at its most fundamental level.
Do you want to know more?
Reach out to our teams today
What is skin biomechanics?
Skin biomechanics refers to all the physical and mechanical properties of the skin: its elasticity, its tensile strength, and its ability to recover its shape after deformation. These properties depend directly on the dermal extracellular matrix (ECM), a three-dimensional network composed mainly of collagen, elastin and hyaluronic acid.
Research has shown that the link between the ECM and the cells that produce it works in both directions. Dermal fibroblasts secrete collagen and elastin, but in return they receive mechanical signals from the ECM that regulate their activity. When collagen integrity is compromised, as is the case during chronological ageing or under the effect of UV rays, mechanotransduction is disrupted. Fibroblasts lose their biochemical reference points, their function deteriorates, and collagen synthesis slows down even further in a well-documented vicious circle.
A study published in Aging Cell in 2023 describes this process precisely: skin ageing manifests itself through a reduction in the thickness and resilience of the dermis, linked to the decrease in the synthesis of ECM components and their increased degradation by aged fibroblasts.
Another study, published in Aging Cell in 2024 and conducted on human samples covering a broad age spectrum, shows that dermal stiffness governs the topography of the epidermis and the basement membrane. With age, the depletion of hemidesmosomes impairs the maintenance of epidermal stem cells, weakening the skin’s regenerative capacity.
The hallmarks of skin ageing: beyond wrinkles
The science of longevity applied to the skin is based on a conceptual framework developed from the work of López-Otín et al., taken up and adapted to dermatology by several recent reviews. A 2023 publication in Aging and Disease identifies seven hallmarks of skin ageing: genomic instability and telomere attrition, epigenetic alterations, loss of proteostasis, dysregulation of the nutrient-sensing system and its signalling pathways, mitochondrial dysfunction, cellular senescence, and altered intercellular communication.
These biological processes do not occur in a linear sequence: they interact, mutually amplify one another, and together accelerate tissue degradation.
Cellular senescence and the SASP phenotype
Cellular senescence deserves particular attention because it directly links cell biology to the visible signs of ageing. Senescent cells stop dividing under the effect of stress, but they remain metabolically active and secrete a group of pro-inflammatory molecules called the SASP (Senescence-Associated Secretory Phenotype). This cocktail includes matrix metalloproteinases (MMP-1, MMP-2, MMP-9), which actively degrade the collagen of the ECM.
A review published in PMC in 2024 on senescent dermal fibroblasts specifies that SASP components maintain autocrine senescence within fibroblasts and, at the same time, propagate senescence to neighbouring cells through paracrine signalling, thereby exacerbating tissue dysfunction across the entire dermis.
Mitochondrial dysfunction and oxidative stress
Cellular energy is at the heart of skin ageing. When mitochondria become dysfunctional, ATP production decreases and the production of free radicals (ROS) increases. This oxidative stress directly impairs fibroblast function, collagen structure and the skin barrier. A review published in Frontiers in Aging in 2025 on longevity cosmeceuticals describes this mitochondrial mechanism precisely as one of the central accelerators of photoageing.
Autophagy, a cellular maintenance mechanism
Autophagy is the process through which cells degrade and recycle their own damaged components. This maintenance mechanism plays a protective role against the accumulation of misfolded proteins and dysfunctional mitochondria. The Aging and Disease review (2023) confirms that autophagy decreases in aged fibroblasts, keratinocytes and melanocytes, contributing to the loss of proteostasis and the progression of skin ageing.
Why conventional anti-wrinkle skincare is no longer enough
As the skin is a mechanical and sensory organ, its long-term health depends on the integrity of its deep structures.
A proteomic and secretomic study on young human fibroblasts (under 35 years old) and aged human fibroblasts (over 55 years old), published in Aging in 2024, shows that cytoskeletal alterations are key markers of fibroblast cellular ageing, resulting in reduced mechanical skin tension and wound-healing defects. These alterations precede visible signs, sometimes by several years.
It is precisely within this time window that longevity skincare is positioned: intervening at the cellular level before the signs of ageing are expressed on the surface.
Active ingredients that target biomechanics and cellular longevity
Bioactive peptides
Les peptides représentent l'une des familles d'actifs les mieux documentées pour la stimulation de la production de collagène. Ils agissent comme messagers biologiques, signalant aux fibroblastes de produire davantage de matrice extracellulaire. Un essai clinique randomisé en double aveugle publié dans Cosmetics en 2024 a démontré qu'une supplémentation en peptides de collagène de bas poids moléculaire réduisait significativement les rides et améliorait l'élasticité cutanée en 6 semaines chez des femmes de 30 ans et plus.
Un essai similaire publié dans Dermatology Research and Practice en 2024, mené avec imagerie par ultrasons haute résolution, a confirmé une augmentation du contenu en collagène dans le derme papillaire après 12 semaines de supplémentation quotidienne en collagène hydrolysé.
Seno-active ingredients: fisetin and EGCG
Peptides represent one of the best-documented families of active ingredients for stimulating collagen production. They act as biological messengers, signalling fibroblasts to produce more extracellular matrix. A randomised double-blind clinical trial published in Cosmetics in 2024 demonstrated that supplementation with low-molecular-weight collagen peptides significantly reduced wrinkles and improved skin elasticity within 6 weeks in women aged 30 and over.
A similar trial published in Dermatology Research and Practice in 2024, conducted using high-resolution ultrasound imaging, confirmed an increase in collagen content in the papillary dermis after 12 weeks of daily supplementation with hydrolysed collagen.
NAD+ and mitochondrial precursors
NAD+ (nicotinamide adenine dinucleotide) is a central coenzyme in cellular energy metabolism. Its level declines with age, contributing to reduced cellular energy and mitochondrial dysfunction. Precursors such as NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) help support cellular lifespan by restoring NAD+ levels and activating sirtuins, proteins involved in DNA repair and the regulation of oxidative stress.
Astaxanthin as a mitochondrial protector
Astaxanthin, a carotenoid extracted from microalgae, activates the Nrf2 pathway (Nuclear Factor Erythroid 2-related Factor, a transcription factor involved in the cellular response to oxidative stress) and exerts a documented mitochondrial protective action. The Frontiers in Aging review (2025) cites data showing that it improves elasticity, hydration and wrinkle reduction by mitigating oxidative damage at the dermal level.
Note: Organic silicon, particularly in the form of silanols, also plays a role in collagen synthesis and the maintenance of dermal structure by activating fibroblasts and participating in the mineralisation of the extracellular matrix.
Formulating longevity skincare: challenges and constraints
The transition from corrective cosmetics to a comprehensive approach centred on skin longevity involves complex formulation choices. Targeting the biological processes responsible for ageing requires active ingredients that are stable, capable of penetrating to the targeted dermal layers, and compatible with the other components of the formula.
The Frontiers in Aging review (2025) emphasises that, unlike marketing-driven products, longevity cosmeceuticals require rigorous scientific validation, combining contributions from dermatology and longevity science. This requirement transforms the criteria used to select active ingredients: increased attention to documented mechanisms of action, measurable biomarkers (dermal density, thickness, hydration, cellular markers), and clinical evaluation methods (high-frequency ultrasound imaging, confocal imaging, proteomic analyses).
The Cureus review (2024) on actionable topical strategies against the hallmarks of skin ageing confirms that combining targeted topical therapies with minimally invasive procedures represents a significant advance in aesthetic medicine, paving the way for personalised strategies to slow visible ageing.
The future of beauty: preventive, cellular, measurable
Skin longevity is not simply a marketing promise. It is a scientific direction structured around precise biological mechanisms, objective biomarkers and active ingredients whose effects are documented at the cellular level. What recent scientific advances make possible is to think of “skin longevity” no longer as an aesthetic ideal, but as a measurable and accessible state of skin health.
Longevity skincare seeks to maintain young and functional cells for as long as possible, regenerate degraded dermal structures, and restore the skin’s natural ability to maintain and repair itself.
It is a proactive approach that fundamentally changes the relationship between healthy skin and skincare. And, according to researchers, it is the only approach that is truly relevant when faced with the biological mechanisms of ageing.
FAQ: skin longevity and skin biomechanics
What is the difference between conventional anti-ageing skincare and longevity skincare?
Longevity skincare targets the biological processes underlying the first signs of ageing and even before they appear: cellular senescence, mitochondrial dysfunction, and degradation of the extracellular matrix. The objective is not to conceal the signs of ageing, but to delay them by maintaining cellular health.
What is cellular senescence and how does it affect the skin?
Cellular senescence refers to the state of a cell that stops dividing after stress (UV exposure, oxidation, telomere shortening) but remains active. Senescent cells secrete inflammatory molecules (SASP) that degrade collagen and spread dysfunction to neighbouring cells. In the dermis, the accumulation of senescent fibroblasts progressively reduces extracellular matrix production and accelerates visible skin ageing.
What role do fibroblasts play in skin ageing?
The fibroblast is the key cell in dermal architecture. It synthesises collagen, elastin and hyaluronic acid, and ensures the homeostasis of the extracellular matrix. With age, fibroblasts age, lose their contractile function and secrete more matrix-degrading enzymes (MMPs). This process is aggravated by the loss of mechanotransduction when the matrix itself is degraded.
Are peptides really effective for collagen production?
Yes, under certain conditions. Randomised double-blind clinical trials, published in 2024 in Cosmetics and Dermatology Research and Practice, show measurable improvements in dermal density, elasticity and wrinkle reduction with hydrolysed collagen peptide supplements. The results are significant after 6 to 12 weeks of daily use. The route of administration (oral vs topical) and the molecular weight of the peptides influence their bioavailability and effectiveness.
What is NAD+ and why is it used in cosmetics?
NAD+ is a central coenzyme in cellular energy metabolism. Its level declines with age, contributing to the reduction in cellular energy and the mitochondrial dysfunction observed in aged fibroblasts and keratinocytes. Precursors such as NMN and niacinamide make it possible to partially restore these levels and support DNA repair through sirtuins. Niacinamide, a precursor of NAD+, is also one of the best-tolerated and best-documented topical active ingredients in dermatology.
How is skin longevity measured objectively?
Several non-invasive methods can be used to assess the biomarkers of skin ageing: high-frequency ultrasound (20–100 MHz) measures dermal thickness and density; confocal microscopy assesses collagen content in vivo; cutometry measures elasticity and skin fatigue; corneometry quantifies epidermal hydration.